Generalized hyperpigmentation with daunorubicin chemotherapy.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 11807454.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Daunorubicin has been reported to cause hyperpigmentation of sun-exposed skin and/or transverse nail pigmentation (3 cases). We report a case of an African American man who had an atypical pattern of generalized hyperpigmentation develop that involved many sun-protected skin areas 2 weeks after daunorubicin treatment. Histopathology of hyperpigmented skin showed increased melanin granules in all epidermal layers. The mechanisms by which daunorubicin may increase skin pigmentation are discussed.
Medical subject headings
- Antibiotics, Antineoplastic
- Daunorubicin
- Hyperpigmentation